Spigen Korea Co., Ltd.

KOSDAQ:A192440 Stock Report

Market Cap: ₩183.6b

Spigen Korea Balance Sheet Health

Financial Health criteria checks 6/6

Spigen Korea has a total shareholder equity of ₩469.6B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩515.5B and ₩45.9B respectively. Spigen Korea's EBIT is ₩35.3B making its interest coverage ratio -4. It has cash and short-term investments of ₩104.2B.

Key information

0%

Debt to equity ratio

₩0

Debt

Interest coverage ratio-4x
Cash₩104.23b
Equity₩469.59b
Total liabilities₩45.93b
Total assets₩515.52b

Recent financial health updates

Recent updates

Shareholders Are Optimistic That Spigen Korea (KOSDAQ:192440) Will Multiply In Value

Apr 13
Shareholders Are Optimistic That Spigen Korea (KOSDAQ:192440) Will Multiply In Value

Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Mar 30
Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 15
Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Is Spigen Korea Co., Ltd. (KOSDAQ:192440) Popular Amongst Insiders?

Mar 01
Is Spigen Korea Co., Ltd. (KOSDAQ:192440) Popular Amongst Insiders?

Spigen Korea (KOSDAQ:192440) Shareholders Have Enjoyed A 42% Share Price Gain

Feb 16
Spigen Korea (KOSDAQ:192440) Shareholders Have Enjoyed A 42% Share Price Gain

Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?

Feb 02
Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?

Is Now The Time To Put Spigen Korea (KOSDAQ:192440) On Your Watchlist?

Jan 20
Is Now The Time To Put Spigen Korea (KOSDAQ:192440) On Your Watchlist?

What Do The Returns On Capital At Spigen Korea (KOSDAQ:192440) Tell Us?

Jan 07
What Do The Returns On Capital At Spigen Korea (KOSDAQ:192440) Tell Us?

Is It Smart To Buy Spigen Korea Co., Ltd. (KOSDAQ:192440) Before It Goes Ex-Dividend?

Dec 25
Is It Smart To Buy Spigen Korea Co., Ltd. (KOSDAQ:192440) Before It Goes Ex-Dividend?

Will Weakness in Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Prove Temporary Given Strong Fundamentals?

Dec 14
Will Weakness in Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Prove Temporary Given Strong Fundamentals?

Do Insiders Own Lots Of Shares In Spigen Korea Co., Ltd. (KOSDAQ:192440)?

Dec 01
Do Insiders Own Lots Of Shares In Spigen Korea Co., Ltd. (KOSDAQ:192440)?

Are Spigen Korea's (KOSDAQ:192440) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 17
Are Spigen Korea's (KOSDAQ:192440) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Financial Position Analysis

Short Term Liabilities: A192440's short term assets (₩226.6B) exceed its short term liabilities (₩37.4B).

Long Term Liabilities: A192440's short term assets (₩226.6B) exceed its long term liabilities (₩8.5B).


Debt to Equity History and Analysis

Debt Level: A192440 is debt free.

Reducing Debt: A192440 has no debt compared to 5 years ago when its debt to equity ratio was 2.1%.

Debt Coverage: A192440 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: A192440 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.